These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

172 related articles for article (PubMed ID: 10798184)

  • 1. [Role of endothelium in the etiology and therapy of atherosclerosis].
    Quaschning T; Ruschitzka FT; Maier W; Lüscher TF
    Internist (Berl); 2000 Apr; 41(4):355-62. PubMed ID: 10798184
    [No Abstract]   [Full Text] [Related]  

  • 2. Evaluation and management of atherogenic dyslipidemia: beyond low-density lipoprotein cholesterol.
    Després JP; Lemieux I; Dagenais GR; Cantin B; Lamarche B
    CMAJ; 2001 Nov; 165(10):1331-3. PubMed ID: 11760979
    [No Abstract]   [Full Text] [Related]  

  • 3. [Mechanism of arteriosclerosis and hyperlipidemia].
    Yamada N
    Nihon Naika Gakkai Zasshi; 1992 Nov; 81(11):1819-24. PubMed ID: 1479224
    [No Abstract]   [Full Text] [Related]  

  • 4. [Endothelial dysfunction].
    Nagy J; Csiky B; Kovács T; Wittmann I
    Orv Hetil; 2001 Aug; 142(31):1667-72. PubMed ID: 11556260
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Antioxidants, oxidation of LDL and atherosclerosis].
    Salonen JT; Kovanen PT; Ylä-Herttuala S; Korpela H
    Duodecim; 1991; 107(15):1232-9. PubMed ID: 1365345
    [No Abstract]   [Full Text] [Related]  

  • 6. Hypertension and atherosclerosis.
    Ram CV
    Prim Care; 1991 Sep; 18(3):559-75. PubMed ID: 1946788
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Endothelial factors in the flux of atherogenic plasma proteins into artery walls.
    Born GV; Medina R; Shafi S; Cardona-Sanclemente LE
    Clin Hemorheol Microcirc; 2002; 26(2):107-16. PubMed ID: 12082259
    [No Abstract]   [Full Text] [Related]  

  • 8. Conway Memorial Lecture 2002. The dyslipidaemia of diabetes: lessons in the pathogenesis of atherosclerosis.
    Tomkin GH
    Ir J Med Sci; 2002; 171(4):220-4. PubMed ID: 12647914
    [No Abstract]   [Full Text] [Related]  

  • 9. [Endothelial function in arterial hypertension and other risk factors for the development of atherosclerosis (a review of the literature--2)].
    Soboleva GN; Ivanova OV; Karpov IuA
    Ter Arkh; 1997; 69(9):80-3. PubMed ID: 9411836
    [No Abstract]   [Full Text] [Related]  

  • 10. Anti-lipid deposition effect of HMG-CoA reductase inhibitor, pitavastatin, in a rat model of hypertension and hypercholesterolemia.
    Kumai T; Oonuma S; Matsumoto N; Takeba Y; Taniguchi R; Kamio K; Miyazu O; Koitabashi Y; Sekine S; Tadokoro M; Kobayashi S
    Life Sci; 2004 Mar; 74(17):2129-42. PubMed ID: 14969717
    [TBL] [Abstract][Full Text] [Related]  

  • 11. New insights into the relationship between myocardial perfusion and lipid-lowering.
    Blumenthal RS; Gluckman TJ
    J Am Coll Cardiol; 2003 Aug; 42(4):611-3. PubMed ID: 12932589
    [No Abstract]   [Full Text] [Related]  

  • 12. [NO and atherosclerosis].
    Ohtani K; Egashira K
    Nihon Rinsho; 2004 Sep; 62 Suppl 9():544-7. PubMed ID: 15506446
    [No Abstract]   [Full Text] [Related]  

  • 13. An update on the hyperlipidemias and atherosclerosis.
    Powell RC
    Indiana Med; 1984 Jun; 77(6):441-5. PubMed ID: 6736617
    [No Abstract]   [Full Text] [Related]  

  • 14. [Disorders of lipid metabolism in essential arterial hypertension in young people].
    Bărbulescu A; Suţeanu S
    Med Interna (Bucur); 1973 Jun; 25(6):711-24. PubMed ID: 4793942
    [No Abstract]   [Full Text] [Related]  

  • 15. Natural antioxidant compounds in risk factors for CVD.
    Kaliora AC; Dedoussis GV
    Pharmacol Res; 2007 Aug; 56(2):99-109. PubMed ID: 17572098
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [A new face of atherosclerosis. New discoveries about the role of nitric oxide result in complementary therapy methods].
    Wennmalm A
    Lakartidningen; 1994 Mar; 91(9):843-7. PubMed ID: 8139355
    [No Abstract]   [Full Text] [Related]  

  • 17. Endothelium-derived nitric oxide, endothelin, and platelet vessel wall interaction: alterations in hypercholesterolemia and atherosclerosis.
    Tanner FC; Boulanger CM; Lüscher TF
    Semin Thromb Hemost; 1993; 19(2):167-75. PubMed ID: 8356462
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [What other effects do statins have except their effect on lipids?].
    Tikkanen MJ
    Duodecim; 1998; 114(13):1299-301. PubMed ID: 11552256
    [No Abstract]   [Full Text] [Related]  

  • 19. [Role of nitric oxide and other endothelium-derived factors].
    Stankevicius E; Kevelaitis E; Vainorius E; Simonsen U
    Medicina (Kaunas); 2003; 39(4):333-41. PubMed ID: 12738901
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Studies on the mechanisms of the antiatherogenic effect of Ca-antagonists].
    Birou S
    Igaku Kenkyu; 1988 Apr; 58(2):77-84. PubMed ID: 3245408
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.